期刊文献+

CD4^+ CD25^+调节性T细胞与肿瘤免疫的研究进展

下载PDF
导出
摘要 CD4+CD25+调节性T细胞是CD4+T细胞的一个重要亚群,具有免疫抑制和免疫无能两大功能。CD4+CD25+T细胞与自身免疫性疾病的发生、移植耐受具有密切关联。近几年的研究表明,CD4+CD25+T细胞与肿瘤的发生发展和转归亦有着密切联系。本文就调节性T细胞的作用机制及特点与肿瘤免疫的关系作一综述。
机构地区 三峡大学医学院
出处 《微生物学免疫学进展》 2011年第3期82-84,共3页 Progress In Microbiology and Immunology
基金 湖北省科技厅自然科学基金项目资助 项目编号:2009CDB280 2010年三峡大学医学院本科创新课题
  • 相关文献

参考文献13

  • 1彭启全,李升平,徐立,李锦清.117例肝癌患者外周血调节T细胞水平及其临床意义[J].癌症,2007,26(7):748-751. 被引量:18
  • 2王凌云,曾缨,潘志忠,朱兆华.胃癌患者调节性T细胞胞内外细胞因子的检测及其意义[J].癌症,2007,26(3):270-273. 被引量:7
  • 3雷晓,余佩武,赵永亮,石彦,饶芸,曾冬竹,吴淼,周立新.CD4^+CD25^+调节性T细胞在胃癌患者的表达及其临床意义[J].第三军医大学学报,2006,28(5):397-400. 被引量:9
  • 4Koji Kono,Hiromichi Kawaida,Akihiro Takahashi,Hidemitsu Sugai,Kosaku Mimura,Naoto Miyagawa,Hideo Omata,Hideki Fujii.CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers[J]. Cancer Immunology, Immunotherapy . 2006 (9) 被引量:1
  • 5Subhasis Chattopadhyay,Nitya G. Chakraborty,Bijay Mukherji.Regulatory T cells and tumor immunity[J]. Cancer Immunology, Immunotherapy . 2005 (12) 被引量:1
  • 6Lutsiak ME,Semnani RT,DE Pascalis R,et al.Inhibition ofCD4+CD25+T regulatory cell function implicated in en-hancedimmune response by low-dose cyclophosphamide. Blood . 2005 被引量:1
  • 7Nair S,Boczkowski D,Fassnacht M,et al.Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Research . 2007 被引量:1
  • 8Baecher-Allan C,Anderson DE.Regulatory cells and human cancer. Seminars in Cancer Biology . 2006 被引量:1
  • 9Mihalyo MA,Doody AD,McAleer JP,Nowak EC,Long M,Yang Y,Adler AJ.In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization:implications for adoptive immunotherapy. J Immunol . 2004 被引量:1
  • 10Chen A,Liu S,Park D,et al.Depleting intratumoral CD4+CD25+regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer. Cancer Research . 2007 被引量:1

二级参考文献41

  • 1王凌云,陈映波,冯炼强,彭辉,吴长有,朱兆华.胃癌患者外周血CD4^+CD25^+调节性T细胞的检测及临床意义[J].中国免疫学杂志,2005,21(12):932-935. 被引量:7
  • 2雷晓,余佩武,赵永亮,石彦,饶芸,曾冬竹,吴淼,周立新.CD4^+CD25^+调节性T细胞在胃癌患者的表达及其临床意义[J].第三军医大学学报,2006,28(5):397-400. 被引量:9
  • 3SAKAGUCHI S, SAKAGUCHI N, ASANO M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[ J ]. J Immunol, 1995, 155(3): 1151-1164. 被引量:1
  • 4BAECHER-ALLAN C, BROWN J A, FREEMAN G J, et al. CD4^+CD25 high regulatory cells in human peripheral blood[J]. J Immunol,2001, 167(3) : 1245 - 1253. 被引量:1
  • 5FUJIO K, OKAMOTO A, TAHARA H, et al. Nucleosome-specific regulatory T cells engineered by triple gene transfer suppress a systemic autoimmune disease[J]. J Immunol, 2004, 173(3) : 2118 -2125. 被引量:1
  • 6MAKITA S, KANAI T, OSHIMA S, et al. CD4 + CD25bfight T cellsin human intestinal lamina pmpria as regulatory cells[J]. J Immunol,2004, 173(5): 3119-3130. 被引量:1
  • 7WOLF A M, WOLF D, STEURER M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients [ J ]. Clin Cancer Res,2003,9(2) : 606 -612. 被引量:1
  • 8ONIZUKA S, TAWARA I, SHIMIZU J, et al. Tumor rejection by in vivo administration of anti-CD25 ( interleukin-2 receptor alpha) monoclonal antibody[J]. Cancer Res, 1999, 59(13) : 3128 - 3133. 被引量:1
  • 9SHIMIZU J, YAMAZAKI S, SAKAGUCHI S, Induction of tumor immunity by removing CD25^+ CD4^+ T cells : a common basis between tumor immunity and autoimmunity[ J ]. J Immunol, 1999, 163 (10) :5211 - 5218. 被引量:1
  • 10DIECKMANN D, PLOTYNER H, BERCHTOLD S, et al. Ex vivo isolation and characterization of CD4^(+) CD25^(+) T cells with regulatory properties from human blood[J]. J Exp Med, 2001, 193(11) : 1303 -1310. 被引量:1

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部